Data in support of optimized production of angiotensin-I converting enzyme inhibitory peptides derived from proteolytic hydrolysate of bitter melon seed proteins
Anugerah Dany Priyanto,
Robert J. Doerksen,
Chi-I Chang,
Wang-Chou Sung,
Simon Bambang Widjanarko,
Joni Kusnadi,
Ya-Chi Lin,
Ting-Chin Wang,
Jue-Liang Hsu
Affiliations
Anugerah Dany Priyanto
Department of Biological Science and Technology, National Pingtung University of Science and Technology, Pingtung 91201, Taiwan
Robert J. Doerksen
Department of BioMolecular Sciences and Research Institute of Pharmaceutical Sciences, University of Mississippi, MS 38677, United States
Chi-I Chang
Department of Biological Science and Technology, National Pingtung University of Science and Technology, Pingtung 91201, Taiwan
Wang-Chou Sung
Vaccine Research and Development Center, National Health Research Institutes, Miaoli 35053, Taiwan
Simon Bambang Widjanarko
Department of Food Science, Faculty of Agricultural Technology, University of Brawijaya, Malang 65145, Indonesia
Joni Kusnadi
Department of Food Science, Faculty of Agricultural Technology, University of Brawijaya, Malang 65145, Indonesia
Ya-Chi Lin
Department of Biological Science and Technology, National Pingtung University of Science and Technology, Pingtung 91201, Taiwan
Ting-Chin Wang
Department of Biological Science and Technology, National Pingtung University of Science and Technology, Pingtung 91201, Taiwan
Jue-Liang Hsu
Department of Biological Science and Technology, National Pingtung University of Science and Technology, Pingtung 91201, Taiwan
VY-7 has been demonstrated as a potent ACE inhibitory peptide in the previous study [1]. In this article, we provide accompanying data about the identification of bitter melon seed proteins (BMSPs), and quantitative analysis and optimized production of VY-7 in BMSPs hydrolysate.
